News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Hidehito Horinouchi: iDFS reliably predicts final OS in breast cancer
Hidehito Horinouchi/X
Feb 7, 2025, 14:07

Hidehito Horinouchi: iDFS reliably predicts final OS in breast cancer

Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X about a recent paper by Fabio Conforti et al. published in the Journal of Clinical Oncology:

“Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer.

iDFS is an acceptable surrogate endpoint to confidently anticipate the final OS.

Dr. Fabio Conforti.”

“Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer”

Authors: Fabio Conforti, Valentina Nekljudova, Isabella Sala, Richard Gelber, Sibylle Loibl et al.

Hidehito Horinouchi: iDFS reliably predicts final OS in breast cancer

More posts featuring Hidehito Horinouchi.

Breast Cancer cancer Fabio Conforti Hidehito Horinouchi IDFS Isabella Sala OncoDaily Oncology Richard Gelber Sibylle Loibl Valentina Nekljudova
Special Coverage
Blog
May 9, 2025, 15:11
Isabel Mestres: Despite everything we do, Cancer continues to touch us all, giving us no rest
Science
May 9, 2025, 15:02
Aakash Desai: New insights in BRAFV600–mutated NSCLC
Blog
May 9, 2025, 14:59
Jay Bhattacharya Congratulates Casey Means on Surgeon General Nomination
Science
May 9, 2025, 14:53
Sitna Ali Mwanzi: Navigation helps Cancer Patients Start, Continue and Complete Treatment
Insight
May 9, 2025, 14:48
Exploring PD-L1 in Oral Cavity Cancers: Insights from a Tertiary Care Audit in India - IJSO
Blog
May 9, 2025, 14:34
Maria Concetta La Milia: Patient-Reported Outcomes in Nose Vestibule Interventional Radiotherapy at ESTRO2025
Blog
May 9, 2025, 14:19
Josh Thomas Georgy Highlights DESTINY-Breast11 Results in High-Risk HER2+ Early Breast Cancer
Blog
May 9, 2025, 14:18
Half of Patients Diagnosed With Cancer in 2023 Had a History of Smoking - CRI
Blog
May 9, 2025, 14:08
Aligning Incentives for Value-Based Success: Building Sustainable Oncology Partnerships - CancerX
Blog
May 9, 2025, 14:06
Childhood Cancer at Survivor’s Week 2025: A Celebration of Strength and New Beginnings
Insight
May 9, 2025, 14:05
Maria Babak Receives the 2025 College of Science Teaching Excellence Award
Blog
May 9, 2025, 14:01
Meet the ASCO25 Featured Voices